IGC · IGC Pharma, Inc.
$0.24
-0.02 (-7.34%)
At close · Jul 29
Going-concern doubt
— cleared May 15, 2026
The latest filing states the doubt was alleviated.
“raise substantial doubt about its ability to continue as a going concern. The Company is currently in the clinical trial stage and has not yet achieved profitability. The Company expects to continue to incur significant operating and net losses, as well as negative cash flow from operations, in the near future.”View the 10-Q filed May 15, 2026
Market Cap
$25.92M
Shares
100.09M
Positioning
Aug 21, 2026 · 22 days to expiry · 14 contractsPut / call OI
0.07
Call-heavy positioning
Open interest
659
contracts outstanding
Volume
64
traded today
Max pain
$0.50
$0.26 above spot
ATM implied vol
0.2%
market's expected move
Open interest by strike
Calls
Puts
0.5
1
1.5
2
2.5
5
7.5
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 269 | 10 | — | — | $0.05 | $0.25 | -1 | 0.2% | 1 | 20 | |
| 5 | 5 | — | — | $0.01 | $0.90 | -0.121 | 1305% | 1 | 4 | |
| 1 | 1 | — | — | $0.05 | $1.20 | -0.447 | 824% | 5 | 12 | |
| 0 | — | — | — | — | $1.90 | -0.56 | 782.3% | 2 | 3 | |
| 329 | 30 | — | — | $0.13 | $2.40 | — | — | 1 | 1 | |
| 0 | — | — | — | — | $4.90 | -0.695 | 826.5% | 1 | 2 | |
| 12 | 6 | — | — | $0.05 | $7.40 | -0.695 | 885.4% | 1 | 1 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.